• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    TSX Venture Exchange Stock Maintenance Bulletins

    6/4/24 11:24:00 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $FLGC alert in real time by email

    VANCOUVER, BC, June 4, 2024 /CNW/ -

    TSX VENTURE COMPANIES

    BULLETIN V2024-1678

    CEAPRO INC. ("CZO")

    BULLETIN TYPE: Plan of Arrangement, Remain Halted, Delist

    BULLETIN DATE: June 4, 2024

    TSX Venture Tier 2 Company 

    TSX Venture Exchange (the "Exchange") has accepted for filing documentation in connection with an arrangement agreement dated December 14, 2023, as amended on January 16, 2024, between Ceapro Inc. ("Ceapro") and Aeterna Zentaris Inc. ("Aeterna"), pursuant to which Aeterna acquired all of the issued and outstanding common shares of Ceapro by way of a plan of arrangement under the Canada Business Corporations Act (the "Arrangement"). Under the terms of the Arrangement, Ceapro shareholders received 0.02360 of an Aeterna share for each Ceapro share held. The transaction also provided that all outstanding options of Ceapro were exchanged into securities of Aeterna in accordance with the terms of the Arrangement.

    The Exchange has been advised that the requisite approval of the Arrangement by Ceapro shareholders was received at a special meeting of shareholders held on March 12, 2024, and that the Court of King's Bench of Alberta granted a final order with respect to the Arrangement on March 28, 2024. The Arrangement was completed on June 3, 2024.

    Delisting:

    Effective at the close of business on Thursday, June 6, 2024, the common shares of Ceapro will be delisted from the TSX Venture Exchange.

    For further details, please refer to management information circulars dated March 12, 2024, and filed by Aeterna and Ceapro which are available under each company's profile on SEDAR+, and Ceapro's news releases dated December 14, 2023, February 15, 2024, February 23, 2024, February 26, 2024, March 12, 2024, March 28, 2024, May 17, 2024, and June 3, 2024.

    _______________________________________

    BULLETIN V2024-1679

    JESMOND CAPITAL LTD. ("JES.P")

    BULLETIN TYPE: Resume Trading

    BULLETIN DATE: June 4, 2024

    TSX Venture Tier 2 Company

    Effective at the opening, Thursday, June 6, 2024, the securities of Jesmond Capital Ltd. (the "Company") will resume trading.  Further to the Exchange Bulletin dated January 16, 2023, a news release was issued on May 31, 2024, and April 3, 2024, announcing that the Company will not be proceeding with its proposed transaction.  The transaction contemplated would have constituted a Qualifying Transaction as defined under Exchange Policy 2.4.

    _______________________________________

    BULLETIN V2024-1680

    SLEEPING GIANT CAPITAL CORP. ("SSX")

    [formerly Sleeping Giant Capital Corp. ("SSX.P")]

    BULLETIN TYPE: Resume Trading, Qualifying Transaction-Completed/New Symbol, Non-Brokered –

    Private Placement

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    The common shares of the Company have been halted from trading since January 8, 2024, pending completion of a Qualifying Transaction.

    Resume Trading

    Effective at the opening, Thursday, June 6, 2024, the common shares of Sleeping Giant Capital Corp. will commence trading on TSX Venture Exchange under the symbol "SSX".

    Qualifying Transaction-Completed/New Symbol

    TSX Venture Exchange has accepted for filing the Company's Qualifying Transaction described in its Filing Statement dated May 28, 2024. As a result, at the opening on Thursday, June 6, 2024, the Company will no longer be considered a Capital Pool Company. The Qualifying Transaction includes the following:

    The Qualifying Transaction consists of the arm's length acquisition of non-operated working interests in certain oil and gas assets located in the Gilby, Rosebud, Niton, and Sylvan Lake areas within Alberta from an arm's length vendor (the "Vendor") for consideration of 4,550,000 common shares at a deemed price of $0.15 and cash payment of $175,000.

    4,550,000 common shares issued to the Vendor pursuant to the Qualifying Transaction will be subject to a Tier 2 Value Security Escrow Agreement to be released over a 36-month period. 2,900,000 common shares and 780,000 stock options are subject to a CPC Escrow Agreement to be released over an 18-month period.

    The Company will continue as Sleeping Giant Capital Corp. and trade under the symbol "SSX".

    The Exchange has been advised that the above transaction has been completed.

    In addition, the Exchange has accepted for filing the following:

    Private Placement – Non-Brokered

    TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced on May 28, 2024:

    Financing Type:                         

    Non-Brokered Private Placement





    Gross Proceeds:                       

    $66,899.85





    Offering:                                   

    445,999 Listed Shares





    Offering Price:                         

    $0.15 per Listed Share





    Non-Cash Commissions:           

    Nil





    Public Disclosure:                     

    For further information, please refer to the company's Filing Statement dated

    May 28, 2024, which has been filed on SEDAR+. The Company issued a news

    release on June 3, 2024 confirming closing of the private placement.

    Effective at the opening, Thursday, June 6, 2024, the common shares of Sleeping Giant Capital Corp. will commence trading on TSX Venture Exchange, under the symbol "SSX".

    Capitalization:                                                     Unlimited        shares with no par value of which

                                                                               12,795,999      shares are issued and outstanding

    Escrow:                                                              7,450,000        common shares

    Transfer Agent:                                                             Odyssey Trust Company

    Symbol:                                                                        SSX (same symbol as CPC but with .P removed)

    CUSIP #:                                                                      83126J 10 3      (unchanged)

    The Company is classified as a "Oil and Gas Extraction (except oil sands)" company.

    Company Contact:                    Terry Meek, Chief Executive Officer

    Company Address:                   4200, 888-3rd St SW, Calgary, Alberta T2P 5C5

    Company Phone Number:        402-813-3244                             

    Company Email Address:         [email protected]                        

    _______________________________________

    BULLETIN V2024-1681

    TRIGON METALS INC. ("TM")

    BULLETIN TYPE:  Consolidation

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    Pursuant to a resolution passed by shareholders at the annual and special meeting held on April 9, 2024, the Company has consolidated its capital on a five (5) old for one (1) new basis.  The name of the Company has not been changed.

    Effective at the opening June 6, 2024, the common shares of Trigon Metals Inc. will commence trading on TSX Venture Exchange on a consolidated basis. The Company is classified as a 'Mineral Exploration/Development' company.

    Post - Consolidation

    Capitalization:                                          Unlimited       shares with no par value of which

                                                                    43,574,720     shares are issued and outstanding

    Escrow                                                    nil      shares are subject to escrow

    Transfer Agent:                         TSX Trust Company

    Trading Symbol:                       TM                    (UNCHANGED)

    CUSIP Number:                       89620A506        (NEW)

    _______________________________________

    24/06/04 - TSX Venture Exchange Bulletins

    TSX VENTURE COMPANIES

    BULLETIN V2024-1682

    ESKAY MINING CORP. ("ESK")

    BULLETIN TYPE:  Halt

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    Effective at 6:54 a.m. PST, June 4, 2024, trading in the shares of the Company was halted, pending news; this regulatory halt is imposed by Investment Industry Regulatory Organization of Canada, the Market Regulator of the Exchange pursuant to the provisions of Section 10.9(1) of the Universal Market Integrity Rules.

    _______________________________________

    BULLETIN V2024-1683

    FAIRCHILD GOLD CORP. ("FAIR")

    BULLETIN TYPE:  Halt

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    Effective at 10:07 a.m. PST, June 3, 2024, trading in the shares of the Company was halted, pending news; this regulatory halt is imposed by Investment Industry Regulatory Organization of Canada, the Market Regulator of the Exchange pursuant to the provisions of Section 10.9(1) of the Universal Market Integrity Rules.

    _______________________________________

    BULLETIN V2024-1684

    FAIRCHILD GOLD CORP. ("FAIR")

    BULLETIN TYPE:  Resume Trading

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    Effective at 12:00 p.m. PST, June 3, 2024, shares of the Company resumed trading, an announcement having been made.

    _______________________________________

    BULLETIN V2024-1685

    FOUNDERS METALS INC. ("FDR")

    BULLETIN TYPE:  Private Placement-Non-Brokered

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    Financing Type:                        Non-Brokered Private Placement

    Gross Proceeds:                      $10,000,000

    Offering:                                   6,250,000 Listed Shares

    Offering Price:                          $1.60 per Listed Share

    Non-Cash Commissions:                                                                                     Shares           Warrants

                                                    Finders (Aggregate)                                                 N/A                   N/A

    Public Disclosure:                   Refer to the company's news release(s) dated May 17, 2024 and May 24, 2024.

    ______________________________________

    BULLETIN V2024-1686

    GGL RESOURCES CORP. ("GGL")

    BULLETIN TYPE:  Private Placement-Non-Brokered

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    Financing Type:                         Non-Brokered Private Placement

    Gross Proceeds:                       $300,000

    Offering:                                    6,000,000 Listed Shares

    Offering Price:                           $0.05 per Listed Share

    Non-Cash Commissions:                                                                                     Shares           Warrants

                                                      Finders (Aggregate)                                                N/A                   N/A

    Public Disclosure:                     Refer to the company's news release(s) dated February 13, 2024, March 27, 2024 and May 30, 2024

    _______________________________________

    BULLETIN V2024-1687

    LIFEIST WELLNESS INC. ("LFST")

    BULLETIN TYPE:  Property-Asset or Share Disposition Agreement

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 1 Company

    TSX Venture Exchange has accepted for filing documentation with respect to the arm's length disposition of all of the issued and outstanding shares of Australian Vaporizers Pty. Ltd., a wholly owned Australian subsidiary of the company.

    As consideration, the Company will receive approximately $900,000, payable in shares of Flora Growth Corp. (NASDAQ:FLGC).

    For further details, please refer to the Company's news release dated May 28, 2024.

    _______________________________________

    BULLETIN V2024-1688

    NOUVEAU MONDE GRAPHITE INC. ("NOU")

    BULLETIN TYPE:  Shares for Debt

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    TSX Venture Exchange has accepted for filing the Company's proposal to issue 18,750,000 common shares at a deemed price of US$2.00 per share and 18,750,000 common share purchase warrants at a price of USD$2.38 per share for a period ending at the earlier of the date upon which investors complete the financing relating to FID and five years from the date of issuance, with an aggregate value of US$37,500,000, in settlement of a debt relating unsecured convertible notes (the "Notes") issued in connection with the private placement announced by press release dated November 8, 2022:

    Number of Creditors:                             2 creditors

    Non Arm's Length Party / ProGroup Participation:

    Name

    Non Arm's Length Party = NP / ProGroup = P

    # of shares

    Aggregate Non-Arm's length Party

    Involvement

    (2 Placees)

    NP

    18,750,000







    TSX Venture Exchange has also accepted for filing the Company's proposal to issue 232,191 common shares at a deemed price of US$2.07 per share and having an aggregate value of US$480,635.37, in settlement of a debt relating to accrued interest under the Notes issued in connection with the private placement announced by press release dated November 8, 2022:

    Number of Creditors:                             2 creditors

    Non Arm's Length Party / ProGroup Participation:

    Name

    Non Arm's Length Party = NP / ProGroup =

    P

    # of

    shares

    Aggregate Non-Arm's length Party

    Involvement

    (2 Placees)

    NP

    232,191







    For more information, please refer to the Company's a press release dated February 15, 2024.

    NOUVEAU MONDE GRAPHITE INC. (« NOU »)

    TYPE DE BULLETIN :  Émission d'actions en règlement d'une dette

    DATE DU BULLETIN : 4 juin 2024

    Société du groupe 2 de Bourse de Croissance TSX

    Bourse de Croissance TSX a accepté le dépôt de la documentation de la société en vertu de l'émission proposée de 18 750 000 actions ordinaires à un prix de 2,00 $US par action et 18 750 000 bons de souscription d'actions ordinaires au prix de 2,38 $ US par action pour une période se terminant à la première des dates suivantes - la date à laquelle les investisseurs finalisent le financement relatif au FID ou à cinq ans à compter de la date d'émission, pour un montant total de 37 500 000 $US, en règlement des billets convertibles non garantis (les « Billets ») émis dans le cadre du placement privé annoncé par voie de communiqué de presse le 8 novembre 2022 :

    Nombre de créanciers :                          2 créanciers

    Participation de personnes ayant un lien de dépendance / Groupe Pro :

    Nom

    Personnes ayant un lien de dépendance

    = NP / Groupe Pro = P

    # d'actions

    Participation totale de personnes ayant

    un lien de dépendance

    (2 souscripteurs)

    NP

    18 750 000







    Bourse de Croissance TSX a également accepté le dépôt de la documentation de la société en vertu de l'émission proposée de 232 191 actions ordinaires à un prix de 2,07 $US par action pour un montant total de 480 635,37 $US, en règlement d'intérêts courus aux termes des Billets émis dans le cadre du placement privé annoncé par voie de communiqué de presse le 8 novembre 2022 :

    Participation de personnes ayant un lien de dépendance / Groupe Pro :

    Nom

    Personnes ayant un lien de dépendance

    = NP / Groupe Pro = P

    # d'actions

    Participation totale de personnes ayant

    un lien de dépendance

    (2 souscripteurs)

    NP

    232 191

    Pour plus d'informations, veuillez-vous référer au communiqué de presse émis par la société le 15 février 2024.

                                                    ________________________________________

    BULLETIN V2024-1689

    P2 GOLD INC.  ("PGLD")

    BULLETIN TYPE:  Halt

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    Effective at 9:54 a.m. PST, June 4, 2024, trading in the shares of the Company was halted, pending news; this regulatory halt is imposed by Investment Industry Regulatory Organization of Canada, the Market Regulator of the Exchange pursuant to the provisions of Section 10.9(1) of the Universal Market Integrity Rules.

    _______________________________________

    BULLETIN V2024-1690

    PINNACLE SILVER AND GOLD CORP. ("PINN")

    BULLETIN TYPE:  Private Placement-Non-Brokered

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    Financing Type:                         Non-Brokered Private Placement

    Gross Proceeds:                       $519,999.99

    Offering:                                    17,333,333 Listed Shares with 8,666,665 warrants attached

    Offering Price:                           $0.03 per Listed Share

    Warrant Exercise Terms:           $0.05 per warrant for a two-year period

    Non-Cash Commissions:                                                                                     Shares           Warrants

                                                      Finders (Aggregate)                                                 N/A             255,000

                                                      Commission Terms: Each non-transferable warrant is exercisable at $0.05 for a two-year period

    Public Disclosure:                     Refer to the company's news release(s) dated April 12, 2024 and May 29, 2024.

    _______________________________________

    BULLETIN V2024-1691

    PROGRESSIVE PLANET SOLUTIONS INC. ("PLAN")

    BULLETIN TYPE:  Normal Course Issuer Bid

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    TSX Venture Exchange has been advised by the Company that pursuant to a Notice of Intention to make a Normal Course Issuer Bid dated May 31, 2024, it may repurchase for cancellation, up to 5,624,847 shares in its own capital stock.  The purchases are to be made through the facilities of TSX Venture Exchange or other recognized marketplaces during the period June 7, 2024 to June 6, 2025.  Purchases pursuant to the bid will be made by Independent Trading Group on behalf of the Company.

    _______________________________________

    BULLETIN V2024-1692

    Q2 METALS CORP. ("QTWO")

    BULLETIN TYPE:  Warrant Price Amendment

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    TSX Venture Exchange has consented to the reduction in the exercise price of the following warrants:

    Private Placement:

    # of Warrants:                                                     12,908,333

    Expiry Date of Warrants:                                       February 23, 2025

    Original Exercise Price of Warrants:                     $1.25

    New Exercise Price of Warrants:                          $0.60

    These warrants were issued pursuant to a private placement of 12,908,333 flow-through and non-flow-through shares with 12,908,333 share purchase warrants attached, which was accepted for filing by the Exchange effective March 6, 2023.

    _______________________________________

    BULLETIN V2024-1693

    QUEBEC PRECIOUS METALS CORPORATION ("QPM")

    BULLETIN TYPE:  Shares for Debt

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    TSX Venture Exchange has accepted for filing the Company's proposal to issue 457,942 common shares to settle outstanding debt of $38,925.08.

    Number of Creditors:                 3 Creditors

    Non-Arm's Length Party /

    Pro Group Participation:



















    Creditors

    # of

    Creditors

    Amount Owing

    Deemed Price

    per Share

    Aggregate # of

    Shares











    Aggregate Non-Arm's

    Length Party Involvement:

    3

    $38,925.08

    $0.085

    457,942

    Aggregate Pro Group

    Involvement:

    N/A

    N/A

    N/A

    N/A

    For more information, please refer to the Company's press release dated May 28, 2024.

    CORPORATION MÉTAUX PRÉCIEUX DU QUÉBEC (« QPM »)

    TYPE DE BULLETIN : Émission d'actions en règlement d'une dette

    DATE DU BULLETIN : Le 4 juin 2024

    Société du groupe 2 de TSX Croissance

    Bourse de croissance TSX a accepté le dépôt de la documentation de la société en vertu de l'émission proposée de 457 942 actions ordinaires en règlement d'un montant de dette total de 38 925,08 $.

    Nombre de créanciers :                          3 créanciers

    Participation de personne ayant

    un lien de dépendance / Groupe Pro :   

    Créanciers

    # de

    créanciers

    Montant dû

    Prix réputé par

    action

     # total d'actions











    Participation total de

    personne ayant un lien de

    dépendance:

    3

    38 925,08 $

    0,085 $

    457 942

    Participation total de

    Groupe Pro:

    S/O

    S/O

    S/O

    S/O

    Pour plus d'informations, veuillez-vous référer au communiqué de presse émis par la société le 28 mai 2024.

    _______________________________________

    BULLETIN V2024-1694

    TUKTU RESOURCES LTD. ("TUK")

    BULLETIN TYPE:  Private Placement-Brokered

    BULLETIN DATE:  June 4, 2024

    TSX Venture Tier 2 Company

    Financing Type:                         Brokered Private Placement

    Gross Proceeds:                        $1,347,500

    Offering:                                     26,950,000 Listed Shares with 26,950,000 warrants attached

    Offering Price:                            $0.05 per Listed Share

    Warrant Exercise Terms:            $0.075 per warrant for a 3-year period, subject to an acceleration right.

    Non-Cash Commissions 

    Agents           



    Units



    Warrants

     

    Canaccord Genuity Corp. (Lead)



    1,000,000

    1,854,000



    Commission Terms: Each Unit is comprised of one Listed Share of the 

    Company and one warrant attached, with each warrant entitling the holder to

    purchase one Listed Share at a price of $0.075 for a 3-year period. Each

    finder's warrant is exercisable at $0.05 for a 3-year period, subject to an

    acceleration right.

    Public Disclosure:                     Refer to the company's news release(s) dated April 17, 2024 and May 28, 2024.

    _______________________________________

    SOURCE TSX Venture Exchange

    Cision View original content: http://www.newswire.ca/en/releases/archive/June2024/04/c3348.html

    Get the next $FLGC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FLGC

    DatePrice TargetRatingAnalyst
    11/25/2024$4.00Buy
    Aegis Capital
    10/13/2021$10.00Buy
    Roth Capital
    6/23/2021$6.00Buy
    MKM Partners
    More analyst ratings

    $FLGC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Starke Clifford bought $6,455 worth of shares (6,795 units at $0.95), increasing direct ownership by 13,324% to 6,846 units (SEC Form 4)

      4 - Flora Growth Corp. (0001790169) (Issuer)

      9/17/24 10:17:39 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Wolkin Harold bought $24,255 worth of shares (25,000 units at $0.97) (SEC Form 4)

      4 - Flora Growth Corp. (0001790169) (Issuer)

      9/11/24 5:43:51 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CEO Starke Clifford bought $48 worth of shares (51 units at $0.95), increasing direct ownership by 0.01% to 474,046 units (SEC Form 4)

      4 - Flora Growth Corp. (0001790169) (Issuer)

      9/6/24 5:25:10 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $FLGC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Flora Growth Corp. Closes Acquisition of Australian Vaporizers

      Fort Lauderdale, Florida--(Newsfile Corp. - June 5, 2024) - Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company") has entered into a share purchase agreement (the "Agreement") to acquire of all of the issued and outstanding shares of Australian Vaporizers Pty Limited ("Australian Vaporizers") in exchange for 550,000 Flora common shares, valued at $0.7 million based on the closing price of Flora's common shares on June 3, 2024, subject to working capital adjustments. The transaction closed on June 4, 2024. Australian Vaporizers was founded in 2010 and has become one of the largest online retailers of vaporizers, hardware, and accessories in Australia. It is an online expert for aromathe

      6/5/24 9:20:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lifeist Sells Australian Vapes

      TORONTO, June 05, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV:LFST) (FRANKFURT: M5B) (OTC:LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced the sale of Australian Vaporizers Pty Ltd. ("Aussie Vapes"), its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:FLGC) ("Flora"), a U.S.-based consumer-packaged goods and pharmaceutical distributor serving all 50 states and 28 countries. The sale was completed through a share purchase agreement (the "SPA") entered into between Lifeist, as vendor, and Flora Growth Corp, as purchaser, purs

      6/5/24 7:00:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • TSX Venture Exchange Stock Maintenance Bulletins

      VANCOUVER, BC, June 4, 2024 /CNW/ - TSX VENTURE COMPANIES BULLETIN V2024-1678 CEAPRO INC. ("CZO")BULLETIN TYPE: Plan of Arrangement, Remain Halted, DelistBULLETIN DATE: June 4, 2024TSX Venture Tier 2 Company  TSX Venture Exchange (the "Exchange") has accepted for filing documentation in connection with an arrangement agreement dated December 14, 2023, as amended on January 16, 2024, between Ceapro Inc. ("Ceapro") and Aeterna Zentaris Inc. ("Aeterna"), pursuant to which Aeterna acquired all of the issued and outstanding common shares of Ceapro by way of a plan of arrangement under the Canada Business Corporations Act (the "Arrangement"). Under the terms of the Arrangement, Ceapro shareholder

      6/4/24 11:24:00 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $FLGC
    Financials

    Live finance-specific insights

    See more
    • Flora Growth Sets Third Quarter 2022 Conference Call for November 28, 2022, at 4:30 P.M. ET

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora'' or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, will host its third quarter 2022 earnings call via webcast on Monday, November 28 at 4:30 p.m. ET. During the webcast, Flora management will deliver financial and operational results for the third quarter ended September 30, 2022, and provide updates on Flora's commercial wholesale operations, house of brands and life sciences division strategies. Following the webcast, Flora management will open the call to analysts, media and investors in a Q&A format. Live Webcast Details Date: Monday, November 28, 2022 Time: 4:30 p.m. ET

      11/21/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth to Host Webcast Discussing M&A Activity and International Market Opportunities - Wednesday, October 26, 2022

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora'' or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced today that the Company will be hosting an analyst call on Wednesday, October 26, 2022, at 02:00 p.m. EST via webcast to discuss Flora Growth's recent M&A activity and strategic growth opportunities. The conference call and live webcast will invite analysts to pose questions to Flora and Franchise Global Health's leadership teams regarding the recent announcement of the definitive agreement of acquisition between the two companies and the opportunities within the cannabis industry on the global stage. To access this ca

      10/25/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Awarded Best M&A Deal at Benzinga Cannabis Capital Conference

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that the Company received the Best M&A Deal award at Benzinga's 2022 Cannabis Capital Conference in Chicago. "We are honored to receive the award for Best M&A Deal at the Benzinga Cannabis Capital Conference, which recognizes our strategic M&A objectives including acquiring products, expertise, expanding distribution, and customers," said Luis Merchan, Chairman and CEO of Flora. Flora completed the acquisition of JustCBD in February 2022, and it immediately offered the Company an established CPG brand with a por

      9/13/22 7:05:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $FLGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Aegis Capital initiated coverage on Flora Growth with a new price target

      Aegis Capital initiated coverage of Flora Growth with a rating of Buy and set a new price target of $4.00

      11/25/24 8:07:10 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Roth Capital initiated coverage on Flora Growth with a new price target

      Roth Capital initiated coverage of Flora Growth with a rating of Buy and set a new price target of $10.00

      10/13/21 9:00:51 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • MKM Partners initiated coverage on Flora Growth with a new price target

      MKM Partners initiated coverage of Flora Growth with a rating of Buy and set a new price target of $6.00

      6/23/21 5:36:01 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $FLGC
    SEC Filings

    See more
    • SEC Form S-3 filed by Flora Growth Corp.

      S-3 - Flora Growth Corp. (0001790169) (Filer)

      5/14/25 4:02:08 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by Flora Growth Corp.

      10-Q - Flora Growth Corp. (0001790169) (Filer)

      5/13/25 4:56:00 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form D filed by Flora Growth Corp.

      D - Flora Growth Corp. (0001790169) (Filer)

      5/8/25 7:36:37 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $FLGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Woo Edward was granted 50,000 shares, increasing direct ownership by 59% to 134,698 units (SEC Form 4)

      4 - Flora Growth Corp. (0001790169) (Issuer)

      12/17/24 10:22:07 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Wolkin Harold

      4 - Flora Growth Corp. (0001790169) (Issuer)

      12/17/24 10:19:00 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by CFO Vaiman Dany

      4 - Flora Growth Corp. (0001790169) (Issuer)

      12/17/24 10:01:07 AM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $FLGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

      SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

      12/17/24 8:02:53 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

      SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

      12/17/24 8:01:40 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Flora Growth Corp.

      SC 13G/A - Flora Growth Corp. (0001790169) (Subject)

      11/14/24 2:24:54 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $FLGC
    Leadership Updates

    Live Leadership Updates

    See more
    • Flora Growth Corp. Appoints Clifford Starke as Chief Executive Officer and Dany Vaiman as Chief Financial Officer; Regains Compliance with NASDAQ Minimum Bid Requirement

      Fort Lauderdale, Florida--(Newsfile Corp. - June 27, 2023) - Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader serving all 50 states with 15,000+ points of distribution around the world and a pharmaceutical distributor in 28 countries, announced today that Clifford Starke has been appointed as Chief Executive Officer to lead its global operations and Dany Vaiman has been appointed as Chief Financial Officer. Mr. Starke, who previously served as President of the Company, takes over for Hussein Rakine, who resigned as CEO but will remain on the Company's Board of Directors. Mr. Rakine expressed his confidence in the appointment, stating, "Clifford's

      6/27/23 4:05:00 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Flora Growth Corp. Announces the Appointment of Hussein Rakine as CEO and Member of the Board of Directors

      Flora Growth Corp. (NASDAQ:FLGC) ("Flora" or the "Company") a leading cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its board of directors (the "Board") accepted the resignation of Luis Merchan as Chairman of the Board and the Company's Chief Executive Officer (CEO). To fill the vacancies created by Mr. Merchan's resignation, the Board has appointed JustCBD founder, Hussein Rakine, as CEO and member of the board of directors. Of the appointment, former-Chairman and CEO, Luis Merchan said, "At Flora we have consistently placed human capital as a critical part of our M&A strategy. That's why today we are honored to have the former foun

      4/18/23 4:05:00 PM ET
      $FLGC
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • CBD Oil Market to Hit Nearly US$137 Billion by 2029

      FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Aug. 23, 2022 /PRNewswire/ -- The CBD oil market is expected to witness an astounding CAGR of 38.90% from 2021 until 2029, climbing from $9.86 billion to $136.64 billion. There are several reasons behind the projected growth such a growing number of CBD-infused skincare products, increased use of THC and CBD in pain management and treatment, rising sales in both retail stores and online, expanding research, and increasing demand for ingestible products. Governments around the world have also begun opening up more doors for CBD, with a recent Health Canada report suggesting legal framework to broaden retail CBD sales across

      8/23/22 8:50:00 AM ET
      $CGC
      $CRON
      $FLGC
      $OGI
      Medicinal Chemicals and Botanical Products
      Health Care
      Biotechnology: Pharmaceutical Preparations